reports
Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Ye...
Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Year U.S. Brewing and Commercial Partnership NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), a leading global consumer packaged goods company and the fourth-largest craft beer brewer in the United States, today announced that it has entered into an exclusive licensing agreement starting January 1, 2027 with the Carlsberg Group, one of the world’s premier brewing organizations and among the largest globally by revenue. Under the terms of the agreement, Tilray has been granted a m...
Tilray erweitert den pharmazeutischen Zugang im Vereinigten Königreich...
Tilray erweitert den pharmazeutischen Zugang im Vereinigten Königreich durch eine strategische Vereinbarung mit Smartway Pharmaceuticals CC-Pharma-Vereinbarung fördert das Wachstum von Tilray im Vereinigten Königreich und stärkt den Vertrieb über Apotheken- und Krankenhauskanäle NEW YORK und LONDON, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, die Pharmasparte von Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), gab heute bekannt, dass ihr europäisches pharmazeutisches Vertriebsunternehmen CC Pharma eine strategische Vereinbarung mit , einem führenden pharmazeutischen Vertriebspartner...
Tilray élargit son accès aux produits pharmaceutiques au Royaume-Uni g...
Tilray élargit son accès aux produits pharmaceutiques au Royaume-Uni grâce à un accord stratégique avec Smartway Pharmaceuticals L’accord avec CC Pharma renforce la croissance de Tilray au Royaume-Uni, consolidant sa distribution auprès des pharmacies et des hôpitaux NEW YORK et LONDRES, 13 févr. 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, la division pharmaceutique de Tilray Brands, Inc. (Nasdaq : TLRY ; TSX : TLRY), a annoncé aujourd'hui que son activité de distribution pharmaceutique européenne, CC Pharma, a conclu un accord stratégique avec , un partenaire de distribution pharmaceutique...
Tilray Expands UK Pharmaceutical Access Through Strategic Agreement wi...
Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals CC Pharma Agreement Bolsters Tilray’s UK Growth, Strengthening Distribution to Pharmacy and Hospital Channels NEW YORK and LONDON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that its European pharmaceutical distribution business, CC Pharma, has entered into a strategic agreement with , a leading UK-based pharmaceutical distribution partner, to expand the availability of pharmaceutical products...
Liquidity Services Inc: 1 director
A director at Liquidity Services Inc sold 12,939 shares at 33.190USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Liquidity Services Announces First Quarter Fiscal Year 2026 Financial ...
Liquidity Services Announces First Quarter Fiscal Year 2026 Financial Results Strong First Quarter Fueled by Market Share Expansion, Multi-Channel Buyer Participation and Operating Leverage from Technology-Based Platform Momentum BETHESDA, Md., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Liquidity Services (NASDAQ:LQDT; ), the leading global provider of e-commerce marketplaces and software solutions powering the circular economy, today announced its financial results for its fiscal quarter ended December 31, 2025, as compared to the corresponding prior year quarter: Gross Merchandise Volume (G...
CC Pharma von Tilray als eines der 100 innovativsten Unternehmen in De...
CC Pharma von Tilray als eines der 100 innovativsten Unternehmen in Deutschland ausgezeichnet Die Auszeichnung würdigt CC Pharma als innovativen Marktführer und vertrauenswürdigen Partner auf dem europäischen Pharmamarkt DENSBORN, Deutschland, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, die Pharmasparte von Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), gab heute bekannt, dass , ihr europäischer Pharmahändler, zu einem der ernannt wurde. Hierbei handelt es sich um eine der renommiertesten und unabhängigsten Auszeichnungen für Innovation bei kleinen und mittleren Unternehmen des La...
CC Pharma, filiale de Tilray, figure parmi le classement TOP 100 Innov...
CC Pharma, filiale de Tilray, figure parmi le classement TOP 100 Innovator en Allemagne Cette distinction récompense CC Pharma dans son rôle de leader de l’innovation et de partenaire de référence du marché pharmaceutique européen DENSBORN, Allemagne, 04 févr. 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, la division pharmaceutique de Tilray Brands, Inc. (Nasdaq : TLRY ; TSX : TLRY), a annoncé aujourd’hui que , son entreprise européenne de distribution pharmaceutique, a été nommée au , l’une des distinctions indépendantes les plus prestigieuses du pays en matière d’innovation parmi les petite...
Breckenridge Distillery Appoints Romano Beverage for Distribution in I...
Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois Award-winning spirits brand announce new distribution partner to oversee statewide distribution BRECKENRIDGE, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- an award-winning craft distillery and spirits brand owned by (NASDAQ: TLRY; TSX: TLRY), has announced appointment of Romano Beverage, a respected partner, to manage distribution responsibilities within the state. Romano Beverage, a trusted leader in beverage distribution, is now overseeing Breckenridge Distillery’s full spirits collection across Illinois—incl...
Tilray’s CC Pharma Recognized as a TOP 100 Innovator in Germany
Tilray’s CC Pharma Recognized as a TOP 100 Innovator in Germany Award Recognizes CC Pharma as an Innovative Leader and Trusted Partner in the European Pharmaceutical Market DENSBORN, Germany, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that , its European pharmaceutical distribution business, has been named a , one of the country’s most respected and independent recognitions for innovation among small and mid-sized enterprises. CC Pharma operates a nationwide pharmaceutical distribution ne...
Tilray Brands Ignites Championship Sunday: Nationwide Tap Room Events,...
Tilray Brands Ignites Championship Sunday: Nationwide Tap Room Events, Big Game Day Deals, and Fan Experiences Announced Gear up for game day, Sunday, February 8, 2026, with ultimate fan experiences, beer, wings, whiskey, and more at SweetWater Brewing Co., Montauk Brewing Co., Breckenridge Brewery, Blue Point Brewing Co., 10 Barrel Brewing Co., Hop Valley Brewing Co., Terrapin Beer Co., and Atwater Brewery NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, is gearing up for the bi...
Terrapin Beer Co. Turns Up the Volume with a New Brand Identity Rooted...
Terrapin Beer Co. Turns Up the Volume with a New Brand Identity Rooted in Music, Art and Craft Beer Culture A modern visual evolution designed to amplify artistic storytelling across the brand portfolio ATHENS, Ga., Jan. 29, 2026 (GLOBE NEWSWIRE) -- (Terrapin), a craft beer brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), today announced a comprehensive brand refresh. The brand now features new visual interpretations and artist collaborations across packaging, logos, taglines, and more. These new features align seamlessly with its current brand values and signature brand elem...
AXIS Capital Reports Fourth Quarter Net Income Available to Common Sha...
AXIS Capital Reports Fourth Quarter Net Income Available to Common Shareholders of $282 Million, or $3.67 per Diluted Common Share and Operating Income of $250 Million, or $3.25 per Diluted Common Share For the fourth quarter of 2025, the Company reports: Annualized return on average common equity ("ROACE") of 19.4% and annualized operating ROACE of 17.2%Combined ratio of 90.4%Underwriting income of $184 million, an increase of $55 million, or 42%, compared to the fourth quarter of 2024Book value per diluted common share of $77.20, an increase of $3.38, or 4.6%, compared to September 30, 2...
SweetWater 420 Fest Unveils Powerhouse 2026 Lineup: Umphrey’s McGee, T...
SweetWater 420 Fest Unveils Powerhouse 2026 Lineup: Umphrey’s McGee, Thievery Corporation & Chromeo to Headline April 17-18: SweetWater’s Biggest Music Festival Returns—Tickets on Sale Now ATLANTA, Jan. 27, 2026 (GLOBE NEWSWIRE) -- (“SweetWater Brewing” or “SweetWater”), the leading craft beer brand in the Southeast by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), announced the musical lineup for the 2026 Sweetwater 420 Fest taking place April 17-18. The beloved music festival, back for its 21st year, will include headliners like , and for the two-day . The lineup for Friday, A...
- Jonathan Moreland
SCL STEPAN COMPANY
RLI RLI CORP.
LTC LTC PROPERTIES INC.
LPTH LIGHTPATH TECHNOLOGIES INC. CL A
LMNR LIMONEIRA CO.
IPAR INTER PARFUMS INC.
GME GAMESTOP CORP. CLASS A
DAKT DAKTRONICS INC.
CMC COMMERCIAL METALS COMPANY
CGNX COGNEX CORPORATION
CASY CASEY'S GENERAL STORES INC.
CALX CALIX NETWORKS
WHF WHITEFIELD
ADC AGREE REALTY CORPORATION
PAR PAR TECHNOLOGY CORP.
EPD ENTERPRISE PRODUCTS PARTNERS L.P.
FSFG FIRST SAVINGS FINANCIAL GROUP INC.
PLBC PLUMAS BANCORP
GLO CLOUGH GLOBAL OPPORTUNITIES FUND
CLPR CLIPPER REALTY
BOMN BOSTON OMAHA
UA UNDER ARMOUR
NKE INC.
ESQ NIKE INC. CLASS B
FGBI ESQUIRE FINANCIAL HOLDINGS
GRX FIRST GUARANTY BANCSHARES
CABA THE GABELLI HEALTHCARE & WELLNESSRX TRUST
JYNT CABALETTA BIO
ALLY THE JOINT
ALT GMAC LLC
APG ALTIMMUNE INC
ZNTL API GROUP CORP
AVO ZENTALIS PHARMACEUTICALS
IVFH MISSION PRODUCE
TMC INNOVATIVE FOOD HLDG
IMRX TMC THE METALS CO INC
LUCY IMMUNEERING CORP
PMCB INNOVATIVE EYEWEAR INC
GLSI PHARMACYTE BIOTECH INC
VANI GREENWICH LIFESCIENCES INC
ACRV VIVANI MEDICAL INC
SUNS ACRIVON THERAPEUTICS INC
GF SUNRISE REALTY TRUST
MSTR THE NEW GERMANY FUND
MPTI INC.
MIGI MICROSTRATEGY INCORPORATED
SQNS M-TRON INDUSTRIES
INC.
MAWSON INFRASTRUCTURE GROUP INC
SEQUANS COMMUNICATIONS
Tilray Medical rafforza la propria presenza sul mercato italiano con i...
Tilray Medical rafforza la propria presenza sul mercato italiano con il lancio di Tilray Medical Italia e l'ampliamento del proprio portafoglio di prodotti a base di cannabis terapeutica NEW YORK e SAVONA, Italia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, una divisione di Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) e leader mondiale nel settore della cannabis terapeutica, che promuove l'alleanza terapeutica tra pazienti e operatori sanitari per prendere decisioni sanitarie informate e personalizzate, ha annunciato oggi un aggiornamento strategico delle proprie attivit...
Tilray Medical renforce sa présence sur le marché italien avec le lanc...
Tilray Medical renforce sa présence sur le marché italien avec le lancement de Tilray Medical Italia et l’élargissement de son portefeuille de produits à base de cannabis thérapeutique NEW YORK et SAVONE, Italie, 22 janv. 2026 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. (« Tilray ») (Nasdaq : TLRY ; TSX : TLRY) et leader mondial du cannabis thérapeutique, qui favorise l’alliance thérapeutique entre les patients et les professionnels de santé afin de leur permettre de prendre des décisions éclairées et personnalisées en matière de santé, annonce ce jour une mise...
Tilray Medical stärkt die Marktpräsenz in Italien mit der Gründung von...
Tilray Medical stärkt die Marktpräsenz in Italien mit der Gründung von Tilray Medical Italia und einem erweiterten Portfolio an medizinischen Cannabis-Produkten NEW YORK und SAVONA, Italien, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray“) (Nasdaq: TLRY; TSX: TLRY) und ein weltweit führender Anbieter von medizinischem Cannabis, der die therapeutische Allianz zwischen Patienten und medizinischen Fachkräften stärkt, um fundierte, individuelle Gesundheitsentscheidungen zu treffen, gab heute eine strategische Aktualisierung seiner mediz...
SweetWater Introduces Big Trip Double IPA: A Bold New Craft Beer
SweetWater Introduces Big Trip Double IPA: A Bold New Craft Beer The Daytrip IPA series grows with Big Trip - a high-ABV brew full of flavor from the Southeast’s leading craft brand ATLANTA, Jan. 22, 2026 (GLOBE NEWSWIRE) -- (“SweetWater Brewing” or “SweetWater”), the leading craft beer brand in the Southeast by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), today announces the launch of a high-ABV extension of its popular . Big Trip delivers bright citrus notes and a smooth, tropical aroma, all wrapped in a bold 9% ABV profile. “Double IPAs continue to trend in popularity as th...
Tilray Medical Strengthens Italian Market Presence with the Launch of ...
Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio NEW YORK and SAVONA, Italy, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced a strategic update to its medical cannabis operations in Italy with the launch of Tilray Medical Italia, the new name of the ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.